Open·Ingested 46 days ago, not re-verified since

DoW Rare Cancers Idea Development Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)

Posted: Jun 17, 2026
Amount: $7,350,000
Closes: Nov 18, 2026 (in 107 days)

Similar opportunities open now

DoW Rare Cancers Concept AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 58 days
DoW Rare Cancers Resource and Community Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses Nov 2026
DoW Kidney Cancer, Idea Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 56 days
DoW Kidney Cancer, Concept AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 8 days
DoW Duchenne Muscular Dystrophy, Idea Development AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 46 days

Classification and identifiers

Solicitation number: HT942526RCRPIDA
Assistance listing (CFDA): 12.420

Amount

$7,350,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation. Distinctive Features: The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research. Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study. Research should have high potential impact on rare cancers and the patient community.